Phosphoproteomics unveils the mode of action of clinical ATR inhibitors and explains their synergy with Gemcitabine in pancreatic cancer cells. Viability screening of 146 targeted drugs identified ATR ...
Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...
Results: Tumor transcriptomes exhibited higher endothelial cells, oxygenation, proteasome activity, and metabolism in comparison to ascites, but similar percentages of cancer-associated fibroblasts ...
Pancreatic cancer, one of the most formidable, could soon see its treatment transformed. Researchers have identified an enzyme, Mical2, which plays a central role in the progression of this disease.
The causes of the underlying pancreatic disease are listed in Table 1. Seven (25%) had both PA and PPE, 15 (53.6%) had ascites without PPE, and the rest (6; 21.4%) PPE only. There were 14 ...
An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward making the test available for patients. An experimental blood test for ...
Another case showed pancreatic ascites without pancreatic necrosis ( Table 4). We encountered two cases of morbidity: a child with a choledochal cyst developed hemorrhagic pancreatitis that needed ...